Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes.
D002395:Catecholamines / Q000378:metabolism; D003295:Convulsive Therapy; D003863:Depression / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism* / Q000627:therapeutic use; D012110:Reserpine / Q000378:metabolism; D012701:Serotonin / Q000134:cerebrospinal fluid / Q000378:metabolism; D014363:Tryptamines / Q000652:urine; D014364:Tryptophan / Q000627:therapeutic use
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D012701:Serotonin; D012110:Reserpine; D014364:Tryptophan; D007099:Imipramine